This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
UnitedHealth (UNH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
The Zacks Analyst Blog Highlights UnitedHealth, Centene and Molina Healthcare
by Zacks Equity Research
UnitedHealth, Centene and Molina Healthcare are part of the Zacks top Analyst Blog.
This Is Why UnitedHealth Stock Bounced Back, But Is Better to Avoid
by Tirthankar Chakraborty
Does UnitedHealth's Insiders scooping up shares of UNH justify a buy decision today? Let's explore -
Zacks Investment Ideas feature highlights: UnitedHealth Group
by Zacks Equity Research
UnitedHealth Group are part of the Zacks Investment Ideas article.
Zacks Investment Ideas feature highlights: UnitedHealth, Progressive and HCI
by Zacks Equity Research
UnitedHealth, Progressive and HCI are part of the Zacks Investment Ideas article.
Follow UNH Insiders as They Buy $30 Million Worth of Stock?
by Andrew Rocco
Though UnitedHealth Group faces a barrage of negative news, recent heavy insider buying and technical indicators suggest peak pessimism and a potential bottom in the stock.
After 30% Slide, is UNH Stock a Buy? Use the 3-Day Rule to Decide
by Ethan Feller
UnitedHealth Group stock has been rocked following a criminal investigation into the company. Is it time to buy shares?
UnitedHealth Spirals Downward Amid New Criminal Probe: Time to Sell?
by Kaibalya Pravo Dey
UNH's troubles are piling up, from a fresh DOJ criminal probe and rising costs to leadership shakeups and pulled guidance.
Should I Buy UnitedHealth Stock Now That it's Half-Off?
by David Bartosiak
UnitedHealth has been in serious trouble as of late. With the stock cut in half, is now the time to buy?
CVS Health Stock Rallies 38% in May: Is it a Buy Amid PBM Pressure?
by Urmimala Biswas
CVS' pharmacy segment continues to lead the industry, processing over 1.7 billion prescriptions annually while delivering high medication adherence.
Markets Await Retail Sales Data
by Zacks Equity Research
Markets Await Retail Sales Data
No Econ Reports Equals Good News in Pre-Market
by Mark Vickery
Even though the stock market has grown optimistic on global tariff deals, we expect the Fed to pay more attention to economic details.
Stock Market News for May 14, 2025
by Zacks Equity Research
U.S. stocks closed mostly higher on Tuesday, with the S&P 500 bouncing back to positive territory for the year after fresh data hinted at cooling inflation, adding to investor optimism a day after the United States and China reached a trade deal.
Markets Mostly Higher: Dow Kept Down by UNH Selling
by Mark Vickery
While UnitedHealthcare fights another unforeseen headwind, NVIDIA helped the Nasdaq cruise higher.
Core CPI Increased Less Than Expected
by Zacks Equity Research
Core CPI Increased Less Than Expected
CPI Inflation Rate at +2.3%, Earnings Reports Mixed
by Mark Vickery
The Inflation Rate for April came in at a 4-year low to +2.3%, 10 bps beneath expectations.
Is Invesco S&P 100 Equal Weight ETF (EQWL) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for EQWL
UnitedHealth Group Incorporated (UNH) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
UnitedHealth (UNH) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), UnitedHealth (UNH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
by Zacks Equity Research
Sector ETF report for FHLC
Wall Street Shaken as UnitedHealth Tanks Since Q1 Miss: Buy the Dip?
by Kaibalya Pravo Dey
From a valuation perspective, UNH appears expensive compared to its peers despite the drop in price.
UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
UnitedHealth (UNH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
UNH Crashes Post Q1 Earnings: Should You Buy the Dip With ETFs?
by Sweta Killa
UnitedHealth's worst drop in 25 years following dismal earnings presents an opportunity for investors to buy the stock with ETFs.
Why UnitedHealth Group (UNH) is a Top Value Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Stock Market News for Apr 21, 2025
by Zacks Equity Research
U.S. stocks ended mixed on Thursday in a choppy trading session to finish a holiday-shortened week lower as tariff worries continued to dent investors' sentiment.